On ‘Reproductive BioMedicine online’, a study led by GeneraLife team highlight the importance of traceability of cells during all stages of ad IVF treatment: this is a fundamental aspect of treatment, and involves witnessing protocols.
To examine the risks associated with witnessing protocols, a failure mode and effects analysis was carried out in a busy IVF centre, before and after implementation of an electronic witnessing system.
The study confirmed the relatively low risk that mismatches may occur in IVF when a manual witnessing system is used: the introduction of this systems allowed a reduction in the moderate-risk failure mode by two-thirds.
Failure mode and effects analysis of witnessing protocols [RBMO]
